ArticleBMC cardiovascular disorders2026
QT interval prolongation and mortality in sepsis: a retrospective cohort study from the MIMIC-IV database.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSepsis is a leading cause of mortality in patients admitted to the intensive care unit (ICU), and QT prolongation (QTP) is common in critically ill patients. However, the association between QTP and long-term mortality in sepsis remains unexamined.
methodsThis retrospective study included patients meeting the Sepsis-3 criteria upon ICU admission between 2008 and 2019, identified from the Intensive Care Medical Information Mart IV (MIMIC-IV) database. Patients were categorized into two groups based on the presence (QTP group) or absence (non-QTP group) of QTP. Clinical outcomes were compared between patients with and without QTP. We used Kaplan–Meier analysis to compare the 28-day and 1-year all-cause mortality between septic patients with and without QTP. Furthermore, we utilized multivariate regression, propensity score matching (PSM), inverse probability of treatment weighting (IPTW), and a survey-weighted generalized linear model to assess the association of QTP with 28-day and 1-year all-cause mortality in patients with sepsis.
resultsA total of 4,845 patients were enrolled, with 1,424 (29.4%) in the QTP group. Compared with the non-QTP patients, the QTP group had significantly higher 28-day mortality (19.17% vs. 13.15%, p < 0.001) and 1-year mortality (33.99% vs. 24.82%, p < 0.001). Following PSM, the QTP group exhibited significantly higher mortality at both 28-day mortality (18.81% vs. 15.51%, p < 0.05) and 1-year mortality (33.60% vs. 27.64%, p < 0.001) compared to the non-QTP group. Patients in the QTP group exhibited increased risk of both 28-day mortality (adjusted OR = 1.34, 95% CI: 1.11–1.61, p = 0.002) and 1-year mortality (adjusted OR = 1.40, 95% CI: 1.20–1.63, p < 0.001).
conclusionThe incidence of QTP was significantly elevated in ICU patients with sepsis compared with the general population and QTP was associated with increased risk-adjusted 28-day and 1-year mortality in ICU patients with sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.